Zimmer Biomet Holdings, Inc.
ZBH · NYSE · United States · Health Care · HC Equipment & Services
- Coverage
- FY2016–FY2025
- History
- 10 years
- Latest filing
- 10-K · SEC EDGAR
- Reporting
- USD
- Fiscal year end
- December
- Last updated
- Feb 2026
Headline figures
Zimmer Biomet Holdings, Inc. at a glance
In FY2025, Zimmer Biomet Holdings, Inc. reported revenue of USD 8,232 mn, EBITDA of USD 2,450 mn, EBITDA margin of 29.8%.
| USD mn | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 7,679 | 8,232 | |||
| EBITDA | 2,525 | 2,450 | |||
| EBITDA margin | 32.9% | 29.8% | |||
| Free cash flow | 1,296 | 1,473 | |||
| ROIC | 7.4% | 6.1% |
The full 10-year history, every line item and each formula are in the platform.
In the platform
- Stat Book — normalized and as-reported IS, BS and CF
- Up to 10 years of annual and quarterly history
- Peer benchmarking and the stock screener
- Corporate risk scorecard
- DCF model from the filed inputs
- Tearsheet and live Excel formulas